Mathers Edward T. - 09 Jun 2021 Form 4/A - Amendment Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role: Director
Signature: /s/ Sasha Keough, attorney-in-fact
Issuer symbol: RYTM
Transactions as of: 09 Jun 2021
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 16 Jun 2021, 16:16:00 UTC
Date Of Original Report: 11 Jun 2021
Previous filing: 08 Jun 2021
Next filing: 14 Jun 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RYTM	Stock Option (right to buy)	Award	$0	+15,000		$0.000000	15,000	09 Jun 2021	Common Stock	15,000	$18.99	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options fully vest upon the earlier of (i) June 9, 2022 or (ii) the date of the Issuer's next annual meeting of the stockholders.

Remarks:

On June 11, 2021, the Reporting Person filed a Form 4 which inadvertently reported the Date of Earliest Transaction (Item 3) as June 9, 2011 rather than June 9, 2021.